NASDAQ · MCAD
Financial Services · Shell Companies
$10.43
Down-$0.54 (-4.92%)
Updated Aug 23, 2026, 10:20 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
MCAD does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning MCAD.
MCAD research
Company profile and research snapshot.
Mountain Crest Acquisition Corp. II, a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Consensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Oct 27, 2021
Trading Under New Ticker Symbol “BTTX” Expected to Begin Friday, October 29, 2021 Trading Under New Ticker Symbol “BTTX” Expected to Begin Friday, October 29, 2021
GlobeNewswire Inc. · Oct 13, 2021
NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that MCAD’s registration statement on Form S-4 (File No. 333-255493) relating to the previously announced merger of MCAD and Better Therapeutics has been declared effective by the U.S. Securities and Exchange Commission as of October 12, 2021. MCAD also announced that it will hold its special meeting of stockholders (the “Special Meeting”) on October 27, 2021 at 10:00 am Eastern Time to, among other things, allow its stockholders to vote to approve the proposed Business Combination with Better Therapeutics. The Special Meeting will be completely virtual and conducted via live webcast at the following address https://www.cstproxy.com/mcacquisitionii/2021. Stockholders will be able to attend the meeting by using the control number that is printed on their proxy card.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MCAD.
No results
No recent SID articles mention MCAD.
